Recruiting

ACHESS

Sponsor:

New York Presbyterian Hospital

Code:

NCT03388320

Conditions

Liver Diseases, Alcoholic

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

A-CHESS

Study Details

Brief summary:

This is a pilot study examining whether an evidence-based recovery support smartphone application, the Addiction Comprehensive Health Enhancement Support System (A-CHESS), can decrease alcohol recidivism in a previously unstudied group of patients with alcoholic liver disease (ALD).

Conditions

Liver Diseases, Alcoholic

Study ID

NCT03388320

Start date

Apr 24, 2018

Status verified date

Mar, 2019

Completion date

Dec 1, 2021

Anticipated

Primary completion date

Jan 15, 2021

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Alcoholic liver disease
  • Followed or seen at New York Presbyterian Hospital / Weill Cornell Medical Center
  • English speaking
  • Access to a smartphone

Exclusion Criteria:

  • Unable to consent
  • Primary language other than English
  • No access to a smartphone

Study Design

Enrollment

30 participants

Anticipated

Intervention Model

Single group

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Participants receiving A-CHESS

Participants will be provided access to the smartphone application A-CHESS (intervention) that will be downloaded to their phone.

Interventions

A-CHESS

Use of smartphone application: Addiction Comprehensive Health Enhancement Support System (A-CHESS)

Primary outcome measure

  • Rates of recidivism [ Time Frame: 6 months ]

Central Contacts and Locations

Central contacts

Locations

New York Presbyterian Hospital - Weill Cornell Medicine and Columbia University Medical Center

Recruiting

New York, New York, United States, 10021

Contacts

More Information

Sponsor

New York Presbyterian Hospital

Last update posted

Mar 13, 2019

Last verified

Mar, 2019

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by New York Presbyterian Hospital on 2019-03-13.